A Phase 2 Study of the LSD1 Inhibitor Img-7289 (bomedemstat) for the Treatment of Essential Thrombocythemia (ET)
2021 · Blood · 13 citations
https://doi.org/10.1182/blood-2021-148210
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1
Papers
0
Citations
0
h-index
0
i10-index
Hugh Young Rienhoff is an academic researcher from University of Bristol. The author has contributed to research in topics: Coastal and Marine Management.
Click to start Chat